Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Aug 17, 2021)

Date Submitted: May 20, 2021

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

COVID Vaccine and Cardiovascular Signals: An Analysis of Vaccine Adverse Event Reports

  • Yiqing Zhao; 
  • Michael Ison; 
  • Yuan Luo

ABSTRACT

Adverse events (AEs) following COVID vaccination have been intensely monitored. In our study, we analyzed data from a spontaneous reporting system - Vaccine Adverse Event Reporting System and detected signals of AEs following administration of COVID vaccines. We identified several cardiovascular and inflammatory-related AEs that demonstrated high odds ratio. We demonstrated our system can serve as a complementary system to identify and monitor AEs outside of pre-defined outcomes routinely monitored by existing databases or projects.


 Citation

Please cite as:

Zhao Y, Ison M, Luo Y

COVID Vaccine and Cardiovascular Signals: An Analysis of Vaccine Adverse Event Reports

JMIR Preprints. 20/05/2021:30576

DOI: 10.2196/preprints.30576

URL: https://preprints.jmir.org/preprint/30576

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.